RESORBA Synthetic Bone - Bone matrix implant, synthetic

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Available from:

Life Healthcare Pty Ltd

Class:

Class III

Manufactured by:

Biomatlante SA ZA les Quatre Nations 5 Rue Edouard Belin, Vigneux De Bretagne, 44360 France

Therapeutic area:

17751 - Bone matrix implant, synthetic

Therapeutic indications:

The performances of the Synthetic Bone Substitute are the filling of bone defects and the bony ingrowth from local osseous tissue onto the surface of the product (osteoconduction process). The total resorption of the product depends on numerous factors such as its size and volume, the location of the defect, the surgical technique, the health status of the patient. The bone reconstruction time is always inferior to the total resorption time. The Synthetic Bone Substitute is intended for use to reconstruct bony voids or bone gaps of the skeletal system (e.g. extremities, spine and pelvis).

Authorization status:

A

Authorization date:

2022-12-01